Acute myeloid leukemia cells are targeted by the naturally occurring CXCR4 antagonist EPI-X4
Kaiser, L. M.; Harms, M.; Sauter, D.; Rawat, V. P. S.; Glitscher, M.; Hildt, E.; Doehner, K.; Doehner, H.; Muench, J.; Buske, C.
Show abstract
This manuscript has been withdrawn by the authors as no consent could be achieved with regard to data contribution. Based on this no agreement on authorship and/or listing in the acknowledgement section was reached. Therefore, the authors do not wish this work to be cited as reference for the project. If you have any questions, please contact the corresponding author.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- The Synergism Between DHODH Inhibitors and Dipyridamole Leads to Metabolic Lethality in Acute Myeloid Leukemia 96%
- Proteome and phosphoproteome changes associated with prognosis in acute myeloid leukemia 96%
- Acid Ceramidase Inhibitor LCL-805 Antagonizes Akt Signaling and Promotes Iron-Dependent Cell Death in Acute Myeloid Leukemia 96%
Similar papers in this journal
- Combining LSD1 and JAK-STAT inhibition targets Down syndrome-associated myeloid leukemia at its core 96%
- Base edited "universal" donor CAR T cell strategies for acute myeloid leukaemia 95%
- SCD inhibition eradicates AML displaying high de novo fatty acid desaturation and synergizes with chemotherapy 95%
Similar papers in this journal
- Targeting AML Resistance with Two Novel Combinations Demonstrate Superior Efficacy in TP53, HLA-B, MUC4 and FLT3 mutations 96%
- Zebrafish Drug Screening Identifies Erlotinib as an Inhibitor of Wnt/β-Catenin Signaling and Self-Renewal in T-cell Acute Lymphoblastic Leukemia 92%
- Changes in serum CXCL13 levels are associated with outcomes of Colorectal Cancer Patients Undergoing First-Line Oxaliplatin-Based Treatment 91%
Similar papers in this journal
- STAT5-dependent regulation of CDC25A by miR-16 controls proliferation and differentiation in FLT3-ITD acute myeloid leukemia 95%
- Development of Small Molecule MEIS Inhibitors that modulate HSC activity 95%
- Mebendazole for Differentiation Therapy of Acute Myeloid Leukemia Identified by a Lineage Maturation Index 95%
Similar papers in this journal
- Retinoic acid and proteotoxic stress induce AML cell death overcoming stromal cell protection 97%
- PDX models reflect the proteome landscape of pediatric acute lymphoblastic leukemia but divert in select pathways 93%
- In vitro models to mimic tumor endothelial cell-mediated immune cell reprogramming in lung adenocarcinoma 91%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.